Does SOTAGLIFLOZIN Cause Dyspnoea? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Dyspnoea have been filed in association with SOTAGLIFLOZIN (INPEFA). This represents 4.7% of all adverse event reports for SOTAGLIFLOZIN.
22
Reports of Dyspnoea with SOTAGLIFLOZIN
4.7%
of all SOTAGLIFLOZIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Dyspnoea From SOTAGLIFLOZIN?
Of the 22 reports, 2 (9.1%) required hospitalization.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTAGLIFLOZIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does SOTAGLIFLOZIN Cause?
Dizziness (51)
Diarrhoea (45)
Therapy interrupted (28)
Death (24)
Off label use (24)
Headache (21)
Urinary tract infection (21)
Product use issue (20)
Nausea (18)
Fungal infection (16)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which SOTAGLIFLOZIN Alternatives Have Lower Dyspnoea Risk?
SOTAGLIFLOZIN vs SOTALOL
SOTAGLIFLOZIN vs SOTATERCEPT
SOTAGLIFLOZIN vs SOTATERCEPT-CSRK
SOTAGLIFLOZIN vs SOTORASIB
SOTAGLIFLOZIN vs SOTROVIMAB